Join the global fight against canine rabies.
For every dose of Continuum® canine or feline vaccine, Nobivac™ Lyme, or Canine Influenza Vaccine, H3N8* sold in the US, Intervet/Schering-Plough Animal Health will donate a dose of rabies vaccine to save dogs and families in the Serengeti.
Preventing canine rabies is an important way to reduce the incidence of human rabies. Every day, approximately 100 children die from rabies. In Africa, where the domestic dog is a primary cause of human rabies, 25,000 people die every year from this horrible disease. In the Serengeti, rabies boasts the highest fatality rate of any infectious disease, with 84.2% of cases traced back to domestic dogs.
That’s why Intervet/Schering-Plough Animal Health has joined forces with the Afya Serengeti project to help prevent canine rabies and build awareness of the widespread rabies problem.
Backed by donations from organizations like the World Health Organization (WHO) and Intervet/Schering-Plough Animal Health, Afya Serengeti has proved remarkably effective. By its second year, Afya Serengeti had managed to reduce by 82% the number of people needing hospital care for bites from rabid dogs. Intervet/Schering-Plough Animal Health is committed to supporting Afya Serengeti long-term, and we hope that, with your help, we can steadily extend the coverage provided by the program to surrounding districts
Help Here. Change There
Make your vaccinations in US clinics perform double duty. Up to 250,000 doses of rabies vaccine will be donated to the Afya Serengeti project, ensuring that disease protection for pets reaches even farther. This special vaccine donation program is available between September 1 and December 31, 2009. So be sure to purchase your Continuum, Nobivac, and canine influenza vaccines now to ensure that you’re having the greatest impact possible on the dogs and people of the Serengeti. Contact your Intervet/Schering-Plough Animal Health or Distributor representative for more information.
Continuum Canine Range
Vaccine Name | Protects Against | Booster Shot Frequency† |
Continuum DAP | Distemper, adenovirus, and parvovirus | 3-year |
Continuum DAP-R | Distemper, adenovirus, parvovirus, and rabies virus | 3-year |
Continuum DA | Distemper and adenovirus | 3-year |
Continuum P | Parvovirus | 3-year |
ContinuumRabies‡ | Rabies virus | 3-year |
Continuum Feline Range
Vaccine Name | Protects Against | Booster Shot Frequency† |
Continuum Feline HCP | Herpesvirus-1, calicivirus,andpanleukopenia virus | 3-year |
Continuum Feline HCP-R | Herpesvirus-1, calicivirus, panleukopenia virus,andrabies virus | 3-year |
Continuum Feline HC | Herpesvirus-1 virusandcalicivirus | 3-year |
Continuum Feline P | Panleukopenia virus | 3-year |
Continuum Rabies‡ | Rabies virus | 4-year |
Nobivac Vaccines
Vaccine Name | Protects Against | Booster Shot Frequency† |
Nobivac Lyme | Lyme disease caused by Borrelia burgdorferi | 1-year |
Canine Influenza Vaccine
Vaccine Name | Protects Against | Booster Shot Frequency† |
Canine Influenza Vaccine, H3N8* | Type A, subtype H3N8 canine influenza virus | 1-year |
*Canine Influenza Vaccine, H3N8 is a conditionally licensed product.
†Revaccination frequency as indicated on the vaccine label approved by the USDA (the US government agency that regulates animal vaccines).
‡Continuum Rabies is approved for use in cats and dogs. It is approved to provide protection without revaccination for 4 years in cats and for 3 years in dogs. State or county regulations may specify frequency of rabies vaccination.
